ロード中...
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents
Multiple Myeloma (MM), a malignancy of plasma cells, remains incurable despite the use of conventional and novel therapies. Halofuginone (HF), a synthetic derivative of quinazolinone alkaloid, has recently been shown to have anti-cancer activity in various preclinical settings. This study demonstrat...
保存先:
| 出版年: | Br J Haematol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4414398/ https://ncbi.nlm.nih.gov/pubmed/22533681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2012.09120.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|